I don't think it's gimmicky. I think it's a tremendous statement of confidence in our program, ... In the world of interventional cardiology where patients are elderly, diseased, suffering, we don't really think of ourselves as providing gimmicks. |
If you want me to comment on accelerating share decline, I guess I would have to say we don't see it, |
We are very confident in our proposal. We think the (recall) issues are very manageable. |
We see real flaws in the method. We're not dealing with a system that has a lot of precedent and has a lot of transparency. |
We're going to run some new plays, and we think they're going to provide us some more momentum. |
What we get is diversification for Boston Scientific and growth, and we get that through CRM. Clearly, CRM is the key asset here. |